Randomised, double-blind, placebo-controlled, parallel-group trial to investigate the analgesic effect of OROS hydromorphone hydrochloride in comparison with placebo in subjects with moderate to sever...

Update Il y a 4 ans
Reference: EUCTR2006-006911-60

Randomised, double-blind, placebo-controlled, parallel-group trial to investigate the analgesic effect of OROS hydromorphone hydrochloride in comparison with placebo in subjects with moderate to severe pain induced by osteoarthritis of the hip or the knee

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To compare the analgesic effect of OROS hydromorphone hydrochloride with placebo in subjects with moderate to severe pain induced by osteoarthritis (OA) of the hip or knee which has not been adequately controlled by previous treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) or paracetamol. This will be assessed by the Brief Pain Inventory (BPI) item 5 “pain on average”.


Inclusion criteria

  • moderate to severe pain induced by osteoarthritis of the hip or the knee